Bacterial colicin-immunity protein protein purification system
US-2024417426-A1 · Dec 19, 2024 · US
US2016201103A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016201103-A1 |
| Application number | US-201615082464-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 28, 2016 |
| Priority date | Oct 2, 2013 |
| Publication date | Jul 14, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for producing heparosan is provided. Heparosan is produced by culturing an Escherichia bacterium having a heparosan-producing ability and modified so that expression of one or more genes, such as rbsR, rbsK, rbsB, hsrA, glgB, glgX, micF, rcsD, rcsB, ybiX, ybiI, ybiJ, ybiC, ybiB, rfaH, nusG, pcoR, pcoS, pcoE, yhcN, yhcO, aaeB, aaeA, aaeX, g1455, alpA, g1453, yrbA, mlaB, mlaC, mlaD, mlaE, mlaF, yrbG, norW, ybjI, ybjJ, ybjK, rybB, yjjY, yjtD, thrL, thrA, thrB, fruA, psuK, ytfT, yjfF, fbp, yagU, paoA, paoB, gsiC, gsiD, yliE, irp2, irp1, bhsA, ycfS, lepB, rnc, era, dapA, gcvR, bcp, hyfA, rpoE, nadB, yfiC, srmB, g1414, g1413, nuoE, nuoF, nuoG, glmZ, hemY, hemX, hemD, rlmL, artQ, artM, artJ, rlmC, ybjO, yejO, yejM, yejL, rpoS, ygbN, ygbM, ygbL, g3798, g3797, g3796, g3795, g3794, g3793, g3792, ryjA, soxR, soxS, yjcC, yjcB, efeU, and efeO, is/are increased in a medium, and collecting heparosan from the medium.
Opening claim text (preview).
1 . An Escherichia bacterium having a heparosan-producing ability, wherein: the bacterium has been modified so that expression is increased of a gene selected from the group consisting of rpoE, rbsR, rbsK, rbsB, hsrA, glgB, glgX, micF, rcsD, rcsB, ybiX, ybiI, ybiJ, ybiC, ybiB, rfaH, nusG, pcoR, pcoS, pcoE, yhcN, yhcO, aaeB, aaeA, aaeX, g1455, alpA, g1453, yrbA, mlaB, mlaC, mlaD, mlaE, mlaF, yrbG, norW, ybjI, ybjJ, ybjK, rybB, yjjY, yjtD, thrL, thrA, thrB, fruA, psuK, ytfT, yjfF, fbp, yagU, paoA, paoB, gsiC, gsiD, yliE, irp2, irp1, bhsA, ycfS, lepB, rnc, era, dapA, gcvR, bcp, hyfA, nadB, yfiC, srmB, g1414, g1413, nuoE, nuoF, nuoG, glmZ, hemY, hemX, hemD, rlmL, artQ, artM, artJ, rlmC, ybjO, yejO, yejM, yejL, rpoS, ygbN, ygbM, ygbL, g3798, g3797, g3796, g3795, g3794, g3793, g3792, ryjA, soxR, soxS, yjcC, yjcB, efeU, efeO, and combinations thereof. 2 . The bacterium according to claim 1 , which has been modified so that expression of at least the rpoE gene is increased. 3 . The bacterium according to claim 1 , which has been modified so that expression of at least the rfaH gene is increased. 4 . The bacterium according to claim 3 , which has been further modified so that expression is increased of a gene selected from the group consisting of rbsR, rbsK, rbsB, hsrA, glgB, glgX, micF, rcsD, rcsB, ybiX, ybiI, ybiJ, ybiC, ybiB, nusG, pcoR, pcoS, pcoE, yhcN, yhcO, aaeB, aaeA, aaeX, g1455, alpA, g1453, yrbA, mlaB, mlaC, mlaD, mlaE, mlaF, yrbG, norW, ybjI, ybjJ, ybjK, rybB, yjjY, yjtD, thrL, thrA, thrB, fruA, psuK, ytfT, yjfF, fbp, yagU, paoA, paoB, gsiC, gsiD, yliE, irp2, irp1, bhsA, ycfS, and combinations thereof. 5 . The bacterium according to claim 1 , wherein said expression is increased by increasing the copy number of the gene(s), and/or modifying a gene expression control sequence of the gene(s). 6 . The bacterium according to claim 1 , which is Escherichia coli. 7 . The bacterium according to claim 1 , wherein: the rbsB gene is a DNA comprising the nucleotide sequence of positions 800 to 1690 of SEQ ID NO: 29, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 800 to 1690 of SEQ ID NO: 29 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the rbsK gene is a DNA comprising the nucleotide sequence of positions 1816 to 2745 of SEQ ID NO: 29, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 1816 to 2745 of SEQ ID NO: 29 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the rbsR gene is a DNA comprising the nucleotide sequence of positions 2749 to 3741 of SEQ ID NO: 29, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 2749 to 3741 of SEQ ID NO: 29 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the hsrA gene is a DNA comprising the complementary sequence of the nucleotide sequence of positions 3707 to 5134 of SEQ ID NO: 29, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the complementary sequence of the nucleotide sequence of positions 3707 to 5134 of SEQ ID NO: 29 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the glgB gene is a DNA comprising the nucleotide sequence of positions 989 to 3175 of SEQ ID NO: 34, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 989 to 3175 of SEQ ID NO: 34 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the glgX gene is a DNA comprising the nucleotide sequence of positions 3172 to 5145 of SEQ ID NO: 34, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 3172 to 5145 of SEQ ID NO: 34 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the rcsB gene is a DNA comprising the nucleotide sequence of positions 3312 to 3962 of SEQ ID NO: 43, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 3312 to 3962 of SEQ ID NO: 43 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the rcsD gene is a DNA comprising the nucleotide sequence of positions 623 to 3295 of SEQ ID NO: 43, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 623 to 3295 of SEQ ID NO: 43 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the micF gene is a DNA comprising the nucleotide sequence of positions 219 to 311 of SEQ ID NO: 43, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 219 to 311 of SEQ ID NO: 43 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the ybiX gene is a DNA comprising the nucleotide sequence of positions 718 to 1395 of SEQ ID NO: 37, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 718 to 1395 of SEQ ID NO: 37 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the ybiI gene is a DNA comprising the nucleotide sequence of positions 1469 to 1735 of SEQ ID NO: 37, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 1469 to 1735 of SEQ ID NO: 37 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the ybiJ gene is a DNA comprising the nucleotide sequence of positions 2000 to 2260 of SEQ ID NO: 37, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the nucleotide sequence of positions 2000 to 2260 of SEQ ID NO: 37 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the ybiC gene is a DNA comprising the complementary sequence of the nucleotide sequence of positions 2488 to 3574 of SEQ ID NO: 37, or a DNA comprising a nucleotide sequence having an identity of 90% or higher to the complementary sequence of the nucleotide sequence of positions 2488 to 3574 of SEQ ID NO: 37 and is able to increase heparosan-producing ability of an Escherichia bacterium having heparosan-producing ability when expression amount thereof is increased in the bacterium; the ybiB gene is a DNA comprising the complementary sequence of the nucleotide sequence of positions 3715 to 4677 of SEQ ID NO: 37, or a DNA comprising a nucleotide sequence having an identity of 90
Preparation of nitrogen-containing carbohydrates · CPC title
Escherichia (G) · CPC title
Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof · CPC title
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds · CPC title
Vectors or expression systems specially adapted for E. coli · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.